{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:12:41Z","timestamp":1788793961605,"version":"build-2803163510"},"reference-count":312,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"DOI":"10.1038\/s41573-026-01514-3","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:41:36Z","timestamp":1788788496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Strengthening muscle for healthy ageing: innovative treatments for sarcopenia"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0667-0780","authenticated-orcid":false,"given":"Sara","family":"Ancel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4723-5901","authenticated-orcid":false,"given":"Emmeran","family":"Le Moal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-9388","authenticated-orcid":false,"given":"Yu Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-5480","authenticated-orcid":false,"given":"Helen M.","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"1514_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-026-01291-5","author":"A Plaza-Florido","year":"2026","unstructured":"Plaza-Florido, A. et al. The long-lived immune system of centenarians. Nat. Rev. Immunol. https:\/\/doi.org\/10.1038\/s41577-026-01291-5 (2026).","journal-title":"Nat. Rev. Immunol."},{"key":"1514_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/d41586-018-01668-0","volume":"554","author":"I Bellantuono","year":"2018","unstructured":"Bellantuono, I. Find drugs that delay many diseases of old age. Nature 554, 293\u2013295 (2018).","journal-title":"Nature"},{"key":"1514_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.arr.2018.07.005","volume":"47","author":"DJ Wilkinson","year":"2018","unstructured":"Wilkinson, D. J., Piasecki, M. & Atherton, P. J. The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res. Rev. 47, 123\u2013132 (2018).","journal-title":"Ageing Res. Rev."},{"key":"1514_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/jcsm.12147","volume":"7","author":"SD Anker","year":"2016","unstructured":"Anker, S. D., Morley, J. E. & von Haehling, S. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle 7, 512\u2013514 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48, 16\u201331 (2019).","journal-title":"Age Ageing"},{"key":"1514_CR6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","volume":"61","author":"BH Goodpaster","year":"2006","unstructured":"Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A 61, 1059\u20131064 (2006).","journal-title":"J. Gerontol. A"},{"key":"1514_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","volume":"50","author":"I Janssen","year":"2002","unstructured":"Janssen, I., Heymsfield, S. B. & Ross, R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J. Am. Geriatr. Soc. 50, 889\u2013896 (2002).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1514_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bone.2019.05.021","volume":"127","author":"Z Aversa","year":"2019","unstructured":"Aversa, Z., Zhang, X., Fielding, R. A., Lanza, I. & LeBrasseur, N. K. The clinical impact and biological mechanisms of skeletal muscle aging. Bone 127, 26\u201336 (2019).","journal-title":"Bone"},{"key":"1514_CR9","first-page":"859","volume":"10","author":"HJ Denison","year":"2015","unstructured":"Denison, H. J., Cooper, C., Sayer, A. A. & Robinson, S. M. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin. Interv. Aging 10, 859\u2013869 (2015).","journal-title":"Clin. Interv. Aging"},{"key":"1514_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s43587-021-00136-1","volume":"1","author":"E Dent","year":"2021","unstructured":"Dent, E., Woo, J., Scott, D. & Hoogendijk, E. O. Toward the recognition and management of sarcopenia in routine clinical care. Nat. Aging 1, 982\u2013990 (2021).","journal-title":"Nat. Aging"},{"key":"1514_CR11","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1042\/CS20230319","volume":"137","author":"A Granic","year":"2023","unstructured":"Granic, A., Suetterlin, K., Shavlakadze, T., Grounds, M. D. & Sayer, A. A. Hallmarks of ageing in human skeletal muscle and implications for understanding the pathophysiology of sarcopenia in women and men. Clin. Sci. 137, 1721\u20131751 (2023).","journal-title":"Clin. Sci."},{"key":"1514_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm15072720","volume":"15","author":"LFJ Huiskamp","year":"2026","unstructured":"Huiskamp, L. F. J., Schaeffers, A. W. M. A., Devriese, L. A. & de Bree, R. The prognostic effect of sarcopenia in solid cancers treated with immunotherapy: a systematic review and meta-analysis. J. Clin. Med. 15, 2720 (2026).","journal-title":"J. Clin. Med."},{"key":"1514_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-024-00550-w","volume":"10","author":"AA Sayer","year":"2024","unstructured":"Sayer, A. A. et al. Sarcopenia. Nat. Rev. Dis. Primers 10, 1\u201316 (2024).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1514_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.14283\/jfa.2019.10","volume":"8","author":"S Goates","year":"2019","unstructured":"Goates, S. et al. Economic impact of hospitalizations in US adults with sarcopenia. J. Frailty Aging 8, 93\u201399 (2019).","journal-title":"J. Frailty Aging"},{"key":"1514_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"S Cohen","year":"2015","unstructured":"Cohen, S., Nathan, J. A. & Goldberg, A. L. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat. Rev. Drug Discov. 14, 58\u201374 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1514_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-021-00279-0","volume":"11","author":"M Murgia","year":"2021","unstructured":"Murgia, M. et al. Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study. Skelet. Muscle 11, 24 (2021).","journal-title":"Skelet. Muscle"},{"key":"1514_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33678-y","volume":"13","author":"P Katti","year":"2022","unstructured":"Katti, P. et al. Mitochondrial network configuration influences sarcomere and myosin filament structure in striated muscles. Nat. Commun. 13, 6058 (2022).","journal-title":"Nat. Commun."},{"key":"1514_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/nu12113367","volume":"12","author":"Y Tamura","year":"2020","unstructured":"Tamura, Y., Omura, T., Toyoshima, K. & Araki, A. Nutrition management in older adults with diabetes: a review on the importance of shifting prevention strategies from metabolic syndrome to frailty. Nutrients 12, 3367 (2020).","journal-title":"Nutrients"},{"key":"1514_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41591-026-04210-2","volume":"32","author":"JA Batsis","year":"2026","unstructured":"Batsis, J. A., Donini, L. M. & Prado, C. M. Unintended risks of sarcopenic obesity during weight-loss interventions in older people. Nat. Med. 32, 776\u2013777 (2026).","journal-title":"Nat. Med."},{"key":"1514_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1532-5415.1977.tb00274.x","volume":"25","author":"M Tomonaga","year":"1977","unstructured":"Tomonaga, M. Histochemical and ultrastructural changes in senile human skeletal muscle. J. Am. Geriatr. Soc. 25, 125\u2013131 (1977).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1514_CR21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1152\/jappl.1994.77.2.493","volume":"77","author":"S Schiaffino","year":"1994","unstructured":"Schiaffino, S. & Reggiani, C. Myosin isoforms in mammalian skeletal muscle. J. Appl. Physiol. 77, 493\u2013501 (1994).","journal-title":"J. Appl. Physiol."},{"key":"1514_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1748-1716.1978.tb06187.x","volume":"103","author":"L Larsson","year":"1978","unstructured":"Larsson, L., Sj\u00f6din, B. & Karlsson, J. Histochemical and biochemical changes in human skeletal muscle with age in sedentary males, age 22\u201365 years. Acta Physiol. Scand. 103, 31\u201339 (1978).","journal-title":"Acta Physiol. Scand."},{"key":"1514_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","volume":"48","author":"R Nilwik","year":"2013","unstructured":"Nilwik, R. et al. The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp. Gerontol. 48, 492\u2013498 (2013).","journal-title":"Exp. Gerontol."},{"key":"1514_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.33549\/physiolres.934371","volume":"69","author":"A Sto\u017eer","year":"2020","unstructured":"Sto\u017eer, A., Vodopivc, P. & Kri\u017ean\u010di\u0107 Bombek, L. Pathophysiology of exercise-induced muscle damage and its structural, functional, metabolic, and clinical consequences. Physiol. Res. 69, 565\u2013598 (2020).","journal-title":"Physiol. Res."},{"key":"1514_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/mus.10510","volume":"29","author":"F Kadi","year":"2004","unstructured":"Kadi, F., Charifi, N., Denis, C. & Lexell, J. Satellite cells and myonuclei in young and elderly women and men. Muscle Nerve 29, 120\u2013127 (2004).","journal-title":"Muscle Nerve"},{"key":"1514_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature11438","volume":"490","author":"JV Chakkalakal","year":"2012","unstructured":"Chakkalakal, J. V., Jones, K. M., Basson, M. A. & Brack, A. S. The aged niche disrupts muscle stem cell quiescence. Nature 490, 355\u2013360 (2012).","journal-title":"Nature"},{"key":"1514_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1126\/science.1144090","volume":"317","author":"AS Brack","year":"2007","unstructured":"Brack, A. S. et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science 317, 807\u2013810 (2007).","journal-title":"Science"},{"key":"1514_CR28","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1126\/science.1087573","volume":"302","author":"IM Conboy","year":"2003","unstructured":"Conboy, I. M., Conboy, M. J., Smythe, G. M. & Rando, T. A. Notch-mediated restoration of regenerative potential to aged muscle. Science 302, 1575\u20131577 (2003).","journal-title":"Science"},{"key":"1514_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nm.3464","volume":"20","author":"BD Cosgrove","year":"2014","unstructured":"Cosgrove, B. D. et al. Rejuvenation of the muscle stem cell population restores strength to injured aged muscles. Nat. Med. 20, 255\u2013264 (2014).","journal-title":"Nat. Med."},{"key":"1514_CR30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.stem.2025.05.012","volume":"32","author":"YX Wang","year":"2025","unstructured":"Wang, Y. X. et al. Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength. Cell Stem Cell 32, 1154\u20131169.e9 (2025).","journal-title":"Cell Stem Cell"},{"key":"1514_CR31","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.stem.2022.10.009","volume":"29","author":"E Porpiglia","year":"2022","unstructured":"Porpiglia, E. et al. Elevated CD47 is a hallmark of dysfunctional aged muscle stem cells that can be targeted to augment regeneration. Cell Stem Cell 29, 1653\u20131668 (2022).","journal-title":"Cell Stem Cell"},{"key":"1514_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1126\/science.ads9175","volume":"391","author":"J Kang","year":"2026","unstructured":"Kang, J. et al. Cellular survivorship bias as a mechanistic driver of muscle stem cell aging. Science 391, 517\u2013521 (2026).","journal-title":"Science"},{"key":"1514_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.tcb.2021.02.006","volume":"31","author":"S Ancel","year":"2021","unstructured":"Ancel, S., Stuelsatz, P. & Feige, J. N. Muscle stem cell quiescence: controlling stemness by staying asleep. Trends Cell Biol. 31, 556\u2013568 (2021).","journal-title":"Trends Cell Biol."},{"key":"1514_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nm.3918","volume":"21","author":"HM Blau","year":"2015","unstructured":"Blau, H. M., Cosgrove, B. D. & Ho, A. T. V. The central role of muscle stem cells in regenerative failure with aging. Nat. Med. 21, 854\u2013862 (2015).","journal-title":"Nat. Med."},{"key":"1514_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.eurger.2015.12.016","volume":"7","author":"S Perkisas","year":"2016","unstructured":"Perkisas, S., De Cock, A., Verhoeven, V. & Vandewoude, M. Physiological and architectural changes in the ageing muscle and their relation to strength and function in sarcopenia. Eur. Geriatr. Med. 7, 201\u2013206 (2016).","journal-title":"Eur. Geriatr. Med."},{"key":"1514_CR36","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jcsm.12901","volume":"13","author":"C Li","year":"2022","unstructured":"Li, C. et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J. Cachexia Sarcopenia Muscle 13, 781\u2013794 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04504-y","volume":"6","author":"G Fitzgerald","year":"2023","unstructured":"Fitzgerald, G. et al. MME+ fibro-adipogenic progenitors are the dominant adipogenic population during fatty infiltration in human skeletal muscle. Commun. Biol. 6, 1\u201321 (2023).","journal-title":"Commun. Biol."},{"key":"1514_CR38","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/s41556-018-0151-y","volume":"20","author":"L Madaro","year":"2018","unstructured":"Madaro, L. et al. Denervation-activated STAT3-IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis. Nat. Cell Biol. 20, 917\u2013927 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.stem.2018.12.014","volume":"24","author":"L Lukjanenko","year":"2019","unstructured":"Lukjanenko, L. et al. Aging disrupts muscle stem cell function by impairing matricellular WISP1 secretion from fibro-adipogenic progenitors. Cell Stem Cell 24, 433\u2013446.e7 (2019).","journal-title":"Cell Stem Cell"},{"key":"1514_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ncb2014","volume":"12","author":"A Uezumi","year":"2010","unstructured":"Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S. & Tsuchida, K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat. Cell Biol. 12, 143\u2013152 (2010).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06068-6","volume":"9","author":"B Malecova","year":"2018","unstructured":"Malecova, B. et al. Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy. Nat. Commun. 9, 3670 (2018).","journal-title":"Nat. Commun."},{"key":"1514_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ncb2015","volume":"12","author":"AWB Joe","year":"2010","unstructured":"Joe, A. W. B. et al. Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis. Nat. Cell Biol. 12, 153\u2013163 (2010).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.673404","volume":"12","author":"M Theret","year":"2021","unstructured":"Theret, M., Rossi, F. M. V. & Contreras, O. Evolving roles of muscle-resident fibro-adipogenic progenitors in health, regeneration, neuromuscular disorders, and aging. Front. Physiol. 12, 673404 (2021).","journal-title":"Front. Physiol."},{"key":"1514_CR44","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.cmet.2021.10.001","volume":"33","author":"J Farup","year":"2021","unstructured":"Farup, J. et al. Human skeletal muscle CD90+ fibro-adipogenic progenitors are associated with muscle degeneration in type 2 diabetic patients. Cell Metab. 33, 2201\u20132214.e10 (2021).","journal-title":"Cell Metab."},{"key":"1514_CR45","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1056\/NEJM199406233302501","volume":"330","author":"MA Fiatarone","year":"1994","unstructured":"Fiatarone, M. A. et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N. Engl. J. Med. 330, 1769\u20131775 (1994).","journal-title":"N. Engl. J. Med."},{"key":"1514_CR46","doi-asserted-by":"publisher","first-page":"7399","DOI":"10.1113\/JP272857","volume":"594","author":"MS Brook","year":"2016","unstructured":"Brook, M. S. et al. Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age-related anabolic resistance to exercise in humans. J. Physiol. 594, 7399\u20137417 (2016).","journal-title":"J. Physiol."},{"key":"1514_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2023.112177","volume":"177","author":"HE Kunz","year":"2023","unstructured":"Kunz, H. E. & Lanza, I. R. Age-associated inflammation and implications for skeletal muscle responses to exercise. Exp. Gerontol. 177, 112177 (2023).","journal-title":"Exp. Gerontol."},{"key":"1514_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1330386","volume":"15","author":"A Tylutka","year":"2024","unstructured":"Tylutka, A., Walas, \u0141 & Zembron-Lacny, A. Level of IL-6, TNF, and IL-1\u03b2 and age-related diseases: a systematic review and meta-analysis. Front. Immunol. 15, 1330386 (2024).","journal-title":"Front. Immunol."},{"key":"1514_CR49","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai, D. et al. IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice. Cell 119, 285\u2013298 (2004).","journal-title":"Cell"},{"key":"1514_CR50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1083\/jcb.200707179","volume":"180","author":"N Bakkar","year":"2008","unstructured":"Bakkar, N. et al. IKK\/NF-\u03baB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis. J. Cell Biol. 180, 787\u2013802 (2008).","journal-title":"J. Cell Biol."},{"key":"1514_CR51","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1083\/jcb.200909117","volume":"188","author":"A Mittal","year":"2010","unstructured":"Mittal, A. et al. The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice. J. Cell Biol. 188, 833\u2013849 (2010).","journal-title":"J. Cell Biol."},{"key":"1514_CR52","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1172\/JCI28721","volume":"116","author":"F Mourkioti","year":"2006","unstructured":"Mourkioti, F. et al. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116, 2945\u20132954 (2006).","journal-title":"J. Clin. Invest."},{"key":"1514_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11091686","volume":"11","author":"Y Ji","year":"2022","unstructured":"Ji, Y. et al. Inflammation: roles in skeletal muscle atrophy. Antioxidants 11, 1686 (2022).","journal-title":"Antioxidants"},{"key":"1514_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-024-07701-9","volume":"632","author":"AA Widjaja","year":"2024","unstructured":"Widjaja, A. A. et al. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. Nature 632, 157\u2013165 (2024).","journal-title":"Nature"},{"key":"1514_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60627-2","volume":"16","author":"J Brorson","year":"2025","unstructured":"Brorson, J. et al. Complementing muscle regeneration-fibro-adipogenic progenitor and macrophage-mediated repair of elderly human skeletal muscle. Nat. Commun. 16, 5233 (2025).","journal-title":"Nat. Commun."},{"key":"1514_CR56","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1152\/japplphysiol.00919.2013","volume":"116","author":"BBL Groen","year":"2014","unstructured":"Groen, B. B. L. et al. Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes. J. Appl. Physiol. 116, 998\u20131005 (2014).","journal-title":"J. Appl. Physiol."},{"key":"1514_CR57","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s43587-022-00250-8","volume":"2","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Characterization of cellular senescence in aging skeletal muscle. Nat. Aging 2, 601\u2013615 (2022).","journal-title":"Nat. Aging"},{"key":"1514_CR58","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s43587-024-00613-3","volume":"4","author":"VR Kedlian","year":"2024","unstructured":"Kedlian, V. R. et al. Human skeletal muscle aging atlas. Nat. Aging 4, 727\u2013744 (2024).","journal-title":"Nat. Aging"},{"key":"1514_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111220","volume":"145","author":"YK Jeon","year":"2021","unstructured":"Jeon, Y. K. et al. Vascular dysfunction as a potential culprit of sarcopenia. Exp. Gerontol. 145, 111220 (2021).","journal-title":"Exp. Gerontol."},{"key":"1514_CR60","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/jcsm.13023","volume":"13","author":"H Lin","year":"2022","unstructured":"Lin, H. et al. Decoding the transcriptome of denervated muscle at single-nucleus resolution. J. Cachexia Sarcopenia Muscle 13, 2102\u20132117 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00296","volume":"6","author":"T Tamaki","year":"2014","unstructured":"Tamaki, T., Hirata, M. & Uchiyama, Y. Qualitative alteration of peripheral motor system begins prior to appearance of typical sarcopenia syndrome in middle-aged rats. Front. Aging Neurosci. 6, 296 (2014).","journal-title":"Front. Aging Neurosci."},{"key":"1514_CR62","doi-asserted-by":"publisher","first-page":"712","DOI":"10.18632\/aging.100926","volume":"8","author":"A Pann\u00e9rec","year":"2016","unstructured":"Pann\u00e9rec, A. et al. A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia. Aging 8, 712\u2013728 (2016).","journal-title":"Aging"},{"key":"1514_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1152\/physrev.00061.2017","volume":"99","author":"L Larsson","year":"2019","unstructured":"Larsson, L. et al. Sarcopenia: aging-related loss of muscle mass and function. Physiol. Rev. 99, 427\u2013511 (2019).","journal-title":"Physiol. Rev."},{"key":"1514_CR64","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1002\/mus.25711","volume":"57","author":"NA Kelly","year":"2018","unstructured":"Kelly, N. A. et al. Quantification and characterization of grouped type I myofibers in human aging. Muscle Nerve 57, E52\u2013E59 (2018).","journal-title":"Muscle Nerve"},{"key":"1514_CR65","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1152\/japplphysiol.00475.2016","volume":"121","author":"SK Hunter","year":"2016","unstructured":"Hunter, S. K., Pereira, H. M. & Keenan, K. G. The aging neuromuscular system and motor performance. J. Appl. Physiol. 121, 982\u2013995 (2016).","journal-title":"J. Appl. Physiol."},{"key":"1514_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8059","volume":"371","author":"AR Palla","year":"2021","unstructured":"Palla, A. R. et al. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science 371, eabc8059 (2021).","journal-title":"Science"},{"key":"1514_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg1485","volume":"15","author":"MA Bakooshli","year":"2023","unstructured":"Bakooshli, M. A. et al. Regeneration of neuromuscular synapses after acute and chronic denervation by inhibiting the gerozyme 15-prostaglandin dehydrogenase. Sci. Transl. Med. 15, eadg1485 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR68","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ncb1101-1014","volume":"3","author":"SC Bodine","year":"2001","unstructured":"Bodine, S. C. et al. Akt\/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell Biol. 3, 1014\u20131019 (2001).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR69","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat. Cell Biol. 3, 1009\u20131013 (2001).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR70","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s42255-020-0251-4","volume":"2","author":"M Hargreaves","year":"2020","unstructured":"Hargreaves, M. & Spriet, L. L. Skeletal muscle energy metabolism during exercise. Nat. Metab. 2, 817\u2013828 (2020).","journal-title":"Nat. Metab."},{"key":"1514_CR71","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2014.12.021","volume":"21","author":"KK Baskin","year":"2015","unstructured":"Baskin, K. K., Winders, B. R. & Olson, E. N. Muscle as a \u2018mediator\u2019 of systemic metabolism. Cell Metab. 21, 237\u2013248 (2015).","journal-title":"Cell Metab."},{"key":"1514_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212219","volume":"14","author":"N Takenaka","year":"2019","unstructured":"Takenaka, N., Araki, N. & Satoh, T. Involvement of the protein kinase Akt2 in insulin-stimulated Rac1 activation leading to glucose uptake in mouse skeletal muscle. PLoS ONE 14, e0212219 (2019).","journal-title":"PLoS ONE"},{"key":"1514_CR73","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"1514_CR74","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1111\/febs.12253","volume":"280","author":"S Schiaffino","year":"2013","unstructured":"Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B. & Sandri, M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 280, 4294\u20134314 (2013).","journal-title":"FEBS J."},{"key":"1514_CR75","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1128\/MCB.24.21.9295-9304.2004","volume":"24","author":"K-MV Lai","year":"2004","unstructured":"Lai, K.-M. V. et al. Conditional activation of Akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell Biol. 24, 9295\u20139304 (2004).","journal-title":"Mol. Cell Biol."},{"key":"1514_CR76","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.2337\/diabetes.48.8.1667","volume":"48","author":"EJ Kurth-Kraczek","year":"1999","unstructured":"Kurth-Kraczek, E. J., Hirshman, M. F., Goodyear, L. J. & Winder, W. W. 5\u2032 AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. Diabetes 48, 1667\u20131671 (1999).","journal-title":"Diabetes"},{"key":"1514_CR77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/jcb.23399","volume":"113","author":"AMJ Sanchez","year":"2012","unstructured":"Sanchez, A. M. J. et al. AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1. J. Cell Biochem. 113, 695\u2013710 (2012).","journal-title":"J. Cell Biochem."},{"key":"1514_CR78","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461 (2011).","journal-title":"Science"},{"key":"1514_CR79","doi-asserted-by":"publisher","first-page":"12017","DOI":"10.1073\/pnas.0705070104","volume":"104","author":"S J\u00e4ger","year":"2007","unstructured":"J\u00e4ger, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1\u03b1. Proc. Natl Acad. Sci. USA 104, 12017\u201312022 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR80","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10522-013-9432-9","volume":"14","author":"M Sandri","year":"2013","unstructured":"Sandri, M. et al. Signalling pathways regulating muscle mass in ageing skeletal muscle: the role of the IGF1-Akt-mTOR-FoxO pathway. Biogerontology 14, 303\u2013323 (2013).","journal-title":"Biogerontology"},{"key":"1514_CR81","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s43587-024-00797-8","volume":"5","author":"X Zuo","year":"2025","unstructured":"Zuo, X. et al. Multi-omic profiling of sarcopenia identifies disrupted branched-chain amino acid catabolism as a causal mechanism and therapeutic target. Nat. Aging 5, 419\u2013436 (2025).","journal-title":"Nat. Aging"},{"key":"1514_CR82","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.A112.399949","volume":"288","author":"PN Quy","year":"2013","unstructured":"Quy, P. N., Kuma, A., Pierre, P. & Mizushima, N. Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation. J. Biol. Chem. 288, 13639 (2013).","journal-title":"J. Biol. Chem."},{"key":"1514_CR83","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2013.03.015","volume":"17","author":"P Castets","year":"2013","unstructured":"Castets, P. et al. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. 17, 731\u2013744 (2013).","journal-title":"Cell Metab."},{"key":"1514_CR84","doi-asserted-by":"publisher","first-page":"583","DOI":"10.18632\/aging.101181","volume":"9","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging. Aging 9, 583\u2013599 (2017).","journal-title":"Aging"},{"key":"1514_CR85","doi-asserted-by":"publisher","first-page":"127","DOI":"10.18632\/aging.100879","volume":"8","author":"LM Baehr","year":"2016","unstructured":"Baehr, L. M. et al. Age-related deficits in skeletal muscle recovery following disuse are associated with neuromuscular junction instability and ER stress, not impaired protein synthesis. Aging 8, 127\u2013146 (2016).","journal-title":"Aging"},{"key":"1514_CR86","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.cmet.2017.04.021","volume":"25","author":"C Tezze","year":"2017","unstructured":"Tezze, C. et al. Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence. Cell Metab. 25, 1374\u20131389.e6 (2017).","journal-title":"Cell Metab."},{"key":"1514_CR87","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.15252\/embj.201593084","volume":"35","author":"D Sebasti\u00e1n","year":"2016","unstructured":"Sebasti\u00e1n, D. et al. Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J. 35, 1677\u20131693 (2016).","journal-title":"EMBO J."},{"key":"1514_CR88","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1096\/fj.13-242750","volume":"28","author":"G Gouspillou","year":"2014","unstructured":"Gouspillou, G. et al. Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans. FASEB J. 28, 1621\u20131633 (2014).","journal-title":"FASEB J."},{"key":"1514_CR89","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/gerona\/glu004","volume":"69","author":"MJ Drummond","year":"2014","unstructured":"Drummond, M. J. et al. Downregulation of E3 ubiquitin ligases and mitophagy-related genes in skeletal muscle of physically inactive, frail older women: a cross-sectional comparison. J. Gerontol. A 69, 1040\u20131048 (2014).","journal-title":"J. Gerontol. A"},{"key":"1514_CR90","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41556-018-0176-2","volume":"20","author":"K Palikaras","year":"2018","unstructured":"Palikaras, K., Lionaki, E. & Tavernarakis, N. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat. Cell Biol. 20, 1013\u20131022 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1514_CR91","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cmet.2011.05.014","volume":"14","author":"DC Andersson","year":"2011","unstructured":"Andersson, D. C. et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab. 14, 196\u2013207 (2011).","journal-title":"Cell Metab."},{"key":"1514_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010037","volume":"22","author":"R Qaisar","year":"2020","unstructured":"Qaisar, R. et al. Restoration of sarcoplasmic reticulum Ca2+ ATPase (SERCA) activity prevents age-related muscle atrophy and weakness in mice. Int. J. Mol. Sci. 22, 37 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1514_CR93","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1073\/pnas.94.2.514","volume":"94","author":"FM Yakes","year":"1997","unstructured":"Yakes, F. M. & Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl Acad. Sci. USA 94, 514\u2013519 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR94","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1086\/507132","volume":"79","author":"E Bua","year":"2006","unstructured":"Bua, E. et al. Mitochondrial DNA-deletion mutations accumulate intracellularly to detrimental levels in aged human skeletal muscle fibers. Am. J. Hum. Genet. 79, 469\u2013480 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"1514_CR95","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s40520-020-01698-7","volume":"33","author":"A Herbst","year":"2021","unstructured":"Herbst, A. et al. Mitochondrial DNA deletion mutations increase exponentially with age in human skeletal muscle. Aging Clin. Exp. Res. 33, 1811\u20131820 (2021).","journal-title":"Aging Clin. Exp. Res."},{"key":"1514_CR96","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/acel.12520","volume":"15","author":"A Herbst","year":"2016","unstructured":"Herbst, A. et al. Latent mitochondrial DNA deletion mutations drive muscle fiber loss at old age. Aging Cell 15, 1132\u20131139 (2016).","journal-title":"Aging Cell"},{"key":"1514_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111802","volume":"163","author":"Z Fan","year":"2022","unstructured":"Fan, Z., Yang, J., Guo, Y., Liu, Y. & Zhong, X. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: association with mitochondrial impairment. Exp. Gerontol. 163, 111802 (2022).","journal-title":"Exp. Gerontol."},{"key":"1514_CR98","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1073\/pnas.0501559102","volume":"102","author":"KR Short","year":"2005","unstructured":"Short, K. R. et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proc. Natl Acad. Sci. USA 102, 5618\u20135623 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR99","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/science.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704\u20131708 (2001).","journal-title":"Science"},{"key":"1514_CR100","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/pnas.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A. & Goldberg, A. L. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl Acad. Sci. USA 98, 14440\u201314445 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR101","doi-asserted-by":"publisher","first-page":"C317","DOI":"10.1152\/ajpcell.00174.2021","volume":"321","author":"C Soendenbroe","year":"2021","unstructured":"Soendenbroe, C., Andersen, J. L. & Mackey, A. L. Muscle-nerve communication and the molecular assessment of human skeletal muscle denervation with aging. Am. J. Physiol. Cell Physiol. 321, C317\u2013C329 (2021).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1514_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40073-8","volume":"14","author":"M Dos Santos","year":"2023","unstructured":"Dos Santos, M. et al. Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolution. Nat. Commun. 14, 4333 (2023).","journal-title":"Nat. Commun."},{"key":"1514_CR103","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829\u2013839 (1998).","journal-title":"Cell"},{"key":"1514_CR104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115\u2013124 (1999).","journal-title":"Cell"},{"key":"1514_CR105","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/gerona\/gls196","volume":"68","author":"PM Coen","year":"2013","unstructured":"Coen, P. M. et al. Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. J. Gerontol. A 68, 447\u2013455 (2013).","journal-title":"J. Gerontol. A"},{"key":"1514_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13694-1","volume":"10","author":"E Migliavacca","year":"2019","unstructured":"Migliavacca, E. et al. Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nat. Commun. 10, 5808 (2019).","journal-title":"Nat. Commun."},{"key":"1514_CR107","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/nature00904","volume":"418","author":"J Lin","year":"2002","unstructured":"Lin, J. et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797\u2013801 (2002).","journal-title":"Nature"},{"key":"1514_CR108","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1073\/pnas.0607795103","volume":"103","author":"M Sandri","year":"2006","unstructured":"Sandri, M. et al. PGC-1\u03b1 protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proc. Natl Acad. Sci. USA 103, 16260\u201316265 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR109","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1101\/gad.1525107","volume":"21","author":"C Handschin","year":"2007","unstructured":"Handschin, C. et al. PGC-1\u03b1 regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 21, 770\u2013783 (2007).","journal-title":"Genes Dev."},{"key":"1514_CR110","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","volume":"307","author":"SC Bodine","year":"2014","unstructured":"Bodine, S. C. & Baehr, L. M. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1. Am. J. Physiol. Endocrinol. Metab. 307, E469\u2013E484 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1514_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7670","volume":"6","author":"G Milan","year":"2015","unstructured":"Milan, G. et al. Regulation of autophagy and the ubiquitin\u2013proteasome system by the FoxO transcriptional network during muscle atrophy. Nat. Commun. 6, 6670 (2015).","journal-title":"Nat. Commun."},{"key":"1514_CR112","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay9592","volume":"13","author":"R Sartori","year":"2021","unstructured":"Sartori, R. et al. Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia. Sci. Transl. Med. 13, eaay9592 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR113","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri, M. et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399\u2013412 (2004).","journal-title":"Cell"},{"key":"1514_CR114","doi-asserted-by":"publisher","first-page":"C1248","DOI":"10.1152\/ajpcell.00104.2009","volume":"296","author":"R Sartori","year":"2009","unstructured":"Sartori, R. et al. Smad2 and 3 transcription factors control muscle mass in adulthood. Am. J. Physiol. Cell Physiol. 296, C1248\u2013C1257 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1514_CR115","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt, T. N. et al. The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395\u2013403 (2004).","journal-title":"Mol. Cell"},{"key":"1514_CR116","doi-asserted-by":"publisher","first-page":"39597","DOI":"10.1074\/jbc.M110.129718","volume":"285","author":"M Altun","year":"2010","unstructured":"Altun, M. et al. Muscle wasting in aged, sarcopenic rats is associated with enhanced activity of the ubiquitin proteasome pathway. J. Biol. Chem. 285, 39597\u201339608 (2010).","journal-title":"J. Biol. Chem."},{"key":"1514_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13832-9","volume":"11","author":"J Segal\u00e9s","year":"2020","unstructured":"Segal\u00e9s, J. et al. Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals. Nat. Commun. 11, 189 (2020).","journal-title":"Nat. Commun."},{"key":"1514_CR118","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-023-00321-3","volume":"13","author":"T Shavlakadze","year":"2023","unstructured":"Shavlakadze, T. et al. Age-related gene expression signatures from limb skeletal muscles and the diaphragm in mice and rats reveal common and species-specific changes. Skelet. Muscle 13, 11 (2023).","journal-title":"Skelet. Muscle"},{"key":"1514_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00030","volume":"5","author":"RJ Stefanetti","year":"2014","unstructured":"Stefanetti, R. J. et al. Ageing has no effect on the regulation of the ubiquitin proteasome-related genes and proteins following resistance exercise. Front. Physiol. 5, 30 (2014).","journal-title":"Front. Physiol."},{"key":"1514_CR120","doi-asserted-by":"publisher","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","volume":"94","author":"AC McPherron","year":"1997","unstructured":"McPherron, A. C. & Lee, S. J. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl Acad. Sci. USA 94, 12457\u201312461 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR121","doi-asserted-by":"publisher","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","volume":"296","author":"AU Trendelenburg","year":"2009","unstructured":"Trendelenburg, A. U. et al. Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am. J. Physiol. Cell Physiol. 296, C1258\u2013C1270 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1514_CR122","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron, A. C., Lawler, A. M. & Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member. Nature 387, 83\u201390 (1997).","journal-title":"Nature"},{"key":"1514_CR123","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1073\/pnas.0604893104","volume":"104","author":"H Amthor","year":"2007","unstructured":"Amthor, H. et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl Acad. Sci. USA 104, 1835\u20131840 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR124","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00125-011-2304-4","volume":"55","author":"C Zhang","year":"2012","unstructured":"Zhang, C. et al. Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia 55, 183\u2013193 (2012).","journal-title":"Diabetologia"},{"key":"1514_CR125","first-page":"343","volume":"6","author":"KE Yarasheski","year":"2002","unstructured":"Yarasheski, K. E., Bhasin, S., Sinha-Hikim, I., Pak-Loduca, J. & Gonzalez-Cadavid, N. F. Serum myostatin-immunoreactive protein is increased in 60\u201392 year old women and men with muscle wasting. J. Nutr. Health Aging 6, 343\u2013348 (2002).","journal-title":"J. Nutr. Health Aging"},{"key":"1514_CR126","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/gerona\/glr025","volume":"66","author":"A Ratkevicius","year":"2011","unstructured":"Ratkevicius, A. et al. Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. J. Gerontol. A 66, 620\u2013626 (2011).","journal-title":"J. Gerontol. A"},{"key":"1514_CR127","doi-asserted-by":"publisher","first-page":"15842","DOI":"10.1073\/pnas.2534946100","volume":"100","author":"NM Wolfman","year":"2003","unstructured":"Wolfman, N. M. et al. Activation of latent myostatin by the BMP-1\/tolloid family of metalloproteinases. Proc. Natl Acad. Sci. USA 100, 15842\u201315846 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR128","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1083\/jcb.201109091","volume":"197","author":"CE Winbanks","year":"2012","unstructured":"Winbanks, C. E. et al. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin. J. Cell Biol. 197, 997\u20131008 (2012).","journal-title":"J. Cell Biol."},{"key":"1514_CR129","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00772-2024","volume":"11","author":"A N\u00fa\u00f1ez-Robainas","year":"2025","unstructured":"N\u00fa\u00f1ez-Robainas, A., Guitart, M., L\u00f3pez-Postigo, A., Sancho-Mu\u00f1oz, A. & Barreiro, E. Myostatin\/Smad2\/Smad3 pathway define a differential clinical phenotype in COPD-associated sarcopenia. ERJ Open Res. 11, 00772-2024 (2025).","journal-title":"ERJ Open Res."},{"key":"1514_CR130","doi-asserted-by":"publisher","first-page":"605","DOI":"10.14336\/AD.2022.1109","volume":"14","author":"B Biagetti","year":"2023","unstructured":"Biagetti, B. & Puig-Domingo, M. Age-related hormones changes and its impact on health status and lifespan. Aging Dis. 14, 605\u2013620 (2023).","journal-title":"Aging Dis."},{"key":"1514_CR131","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman, S. M. et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J. Clin. Endocrinol. Metab. 86, 724\u2013731 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1514_CR132","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10522-013-9425-8","volume":"14","author":"S Sipil\u00e4","year":"2013","unstructured":"Sipil\u00e4, S. et al. Sex hormones and skeletal muscle weakness. Biogerontology 14, 231\u2013245 (2013).","journal-title":"Biogerontology"},{"key":"1514_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-020-03236-y","volume":"21","author":"A Bian","year":"2020","unstructured":"Bian, A. et al. Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly. BMC Musculoskelet. Disord. 21, 214 (2020).","journal-title":"BMC Musculoskelet. Disord."},{"key":"1514_CR134","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","volume":"31","author":"E Ricciotti","year":"2011","unstructured":"Ricciotti, E. & FitzGerald, G. A. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31, 986\u20131000 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1514_CR135","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01301-3","volume":"20","author":"H Huang","year":"2022","unstructured":"Huang, H. et al. The sustained PGE2 release matrix improves neovascularization and skeletal muscle regeneration in a hindlimb ischemia model. J. Nanobiotechnol. 20, 95 (2022).","journal-title":"J. Nanobiotechnol."},{"key":"1514_CR136","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.clim.2006.01.016","volume":"119","author":"JY Park","year":"2006","unstructured":"Park, J. Y., Pillinger, M. H. & Abramson, S. B. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119, 229\u2013240 (2006).","journal-title":"Clin. Immunol."},{"key":"1514_CR137","doi-asserted-by":"publisher","first-page":"6675","DOI":"10.1073\/pnas.1705420114","volume":"114","author":"ATV Ho","year":"2017","unstructured":"Ho, A. T. V. et al. Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proc. Natl Acad. Sci. USA. 114, 6675\u20136684 (2017).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"1514_CR138","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cmet.2011.12.001","volume":"15","author":"A Guerci","year":"2012","unstructured":"Guerci, A. et al. Srf-dependent paracrine signals produced by myofibers control satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 15, 25\u201337 (2012).","journal-title":"Cell Metab."},{"key":"1514_CR139","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068788","volume":"377","author":"R Bernabei","year":"2022","unstructured":"Bernabei, R. et al. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). BMJ 377, e068788 (2022).","journal-title":"BMJ"},{"key":"1514_CR140","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1001\/jama.2014.5616","volume":"311","author":"M Pahor","year":"2014","unstructured":"Pahor, M. et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the life study randomized clinical trial. JAMA 311, 2387\u20132396 (2014).","journal-title":"JAMA"},{"key":"1514_CR141","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.cmet.2016.05.007","volume":"23","author":"GD Cartee","year":"2016","unstructured":"Cartee, G. D., Hepple, R. T., Bamman, M. M. & Zierath, J. R. Exercise promotes healthy aging of skeletal muscle. Cell Metab. 23, 1034\u20131047 (2016).","journal-title":"Cell Metab."},{"key":"1514_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/nu12072057","volume":"12","author":"J McKendry","year":"2020","unstructured":"McKendry, J. et al. Nutritional supplements to support resistance exercise in countering the sarcopenia of aging. Nutrients 12, 2057 (2020).","journal-title":"Nutrients"},{"key":"1514_CR143","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41586-023-06877-w","volume":"629","author":"D Amar","year":"2024","unstructured":"Amar, D. et al. Temporal dynamics of the multi-omic response to endurance exercise training. Nature 629, 174\u2013183 (2024).","journal-title":"Nature"},{"key":"1514_CR144","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.clnu.2018.08.032","volume":"38","author":"E Wesselink","year":"2019","unstructured":"Wesselink, E., Koekkoek, W. A. C., Grefte, S., Witkamp, R. F. & van Zanten, A. R. H. Feeding mitochondria: potential role of nutritional components to improve critical illness convalescence. Clin. Nutr. 38, 982\u2013995 (2019).","journal-title":"Clin. Nutr."},{"key":"1514_CR145","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.molmed.2021.04.009","volume":"27","author":"D D\u2019Amico","year":"2021","unstructured":"D\u2019Amico, D. et al. Impact of the natural compound urolithin A on health, disease, and aging. Trends Mol. Med. 27, 687\u2013699 (2021).","journal-title":"Trends Mol. Med."},{"key":"1514_CR146","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C Lopez-Otin","year":"2013","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217 (2013).","journal-title":"Cell"},{"key":"1514_CR147","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00223-023-01145-5","volume":"114","author":"J Faitg","year":"2024","unstructured":"Faitg, J., D\u2019Amico, D., Rinsch, C. & Singh, A. Mitophagy activation by urolithin A to target muscle aging. Calcif. Tissue Int. 114, 53\u201359 (2024).","journal-title":"Calcif. Tissue Int."},{"key":"1514_CR148","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0319","volume":"13","author":"P Luan","year":"2021","unstructured":"Luan, P. et al. Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy. Sci. Transl. Med. 13, eabb0319 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR149","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nm.4132","volume":"22","author":"D Ryu","year":"2016","unstructured":"Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22, 879\u2013888 (2016).","journal-title":"Nat. Med."},{"key":"1514_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76564-7","volume":"10","author":"N Ghosh","year":"2020","unstructured":"Ghosh, N. et al. Urolithin A augments angiogenic pathways in skeletal muscle by bolstering NAD+ and SIRT1. Sci. Rep. 10, 20184 (2020).","journal-title":"Sci. Rep."},{"key":"1514_CR151","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13662","volume":"21","author":"D D\u2019Amico","year":"2022","unstructured":"D\u2019Amico, D. et al. Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis. Aging Cell 21, e13662 (2022).","journal-title":"Aging Cell"},{"key":"1514_CR152","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1039\/C9FO01332F","volume":"10","author":"X Fu","year":"2019","unstructured":"Fu, X. et al. Urolithin A targets the PI3K\/Akt\/NF-\u03baB pathways and prevents IL-1\u03b2-induced inflammatory response in human osteoarthritis: in vitro and in vivo studies. Food Funct. 10, 6135\u20136146 (2019).","journal-title":"Food Funct."},{"key":"1514_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26944-x","volume":"8","author":"PA Andreux","year":"2018","unstructured":"Andreux, P. A. et al. Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly. Sci. Rep. 8, 8548 (2018).","journal-title":"Sci. Rep."},{"key":"1514_CR154","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s42255-019-0073-4","volume":"1","author":"PA Andreux","year":"2019","unstructured":"Andreux, P. A. et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat. Metab. 1, 595\u2013603 (2019).","journal-title":"Nat. Metab."},{"key":"1514_CR155","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s43587-025-00996-x","volume":"5","author":"D Denk","year":"2025","unstructured":"Denk, D. et al. Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial. Nat. Aging 5, 2309\u20132322 (2025).","journal-title":"Nat. Aging"},{"key":"1514_CR156","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.44279","volume":"5","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial. JAMA Netw. Open 5, e2144279 (2022).","journal-title":"JAMA Netw. Open"},{"key":"1514_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100633","volume":"3","author":"A Singh","year":"2022","unstructured":"Singh, A. et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep. Med. 3, 100633 (2022).","journal-title":"Cell Rep. Med."},{"key":"1514_CR158","first-page":"79","volume":"19","author":"W Christian","year":"1936","unstructured":"Christian W. & Warburg, O. Pyridine, the hydrogen transfusing component of fermentative enzymes. Helv. Chim. Acta 19, 79\u201388 (1936).","journal-title":"Helv. Chim. Acta"},{"key":"1514_CR159","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","volume":"11","author":"C Cant\u00f3","year":"2010","unstructured":"Cant\u00f3, C. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213\u2013219 (2010).","journal-title":"Cell Metab."},{"key":"1514_CR160","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1101\/gad.1650608","volume":"22","author":"D Chen","year":"2008","unstructured":"Chen, D. et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 22, 1753\u20131757 (2008).","journal-title":"Genes Dev."},{"key":"1514_CR161","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.stem.2012.04.002","volume":"10","author":"M Cerletti","year":"2012","unstructured":"Cerletti, M., Jang, Y. C., Finley, L. W. S., Haigis, M. C. & Wagers, A. J. Short-term calorie restriction enhances skeletal muscle stem cell function. Cell Stem Cell 10, 515\u2013519 (2012).","journal-title":"Cell Stem Cell"},{"key":"1514_CR162","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.devcel.2008.02.004","volume":"14","author":"M Fulco","year":"2008","unstructured":"Fulco, M. et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev. Cell 14, 661\u2013673 (2008).","journal-title":"Dev. Cell"},{"key":"1514_CR163","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3, C. et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056\u20131060 (2009).","journal-title":"Nature"},{"key":"1514_CR164","doi-asserted-by":"publisher","first-page":"E117","DOI":"10.1152\/ajpendo.00318.2009","volume":"298","author":"SR Costford","year":"2010","unstructured":"Costford, S. R. et al. Skeletal muscle NAMPT is induced by exercise in humans. Am. J. Physiol. Endocrinol. Metab. 298, E117\u2013E126 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1514_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201968","volume":"13","author":"N Seyedsadjadi","year":"2018","unstructured":"Seyedsadjadi, N. et al. High protein intake is associated with low plasma NAD+ levels in a healthy human cohort. PLoS ONE 13, e0201968 (2018).","journal-title":"PLoS ONE"},{"key":"1514_CR166","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3, C. et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 15, 838\u2013847 (2012).","journal-title":"Cell Metab."},{"key":"1514_CR167","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","volume":"155","author":"AP Gomes","year":"2013","unstructured":"Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624\u20131638 (2013).","journal-title":"Cell"},{"key":"1514_CR168","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","volume":"2","author":"E Katsyuba","year":"2020","unstructured":"Katsyuba, E., Romani, M., Hofer, D. & Auwerx, J. NAD+ homeostasis in health and disease. Nat. Metab. 2, 9\u201331 (2020).","journal-title":"Nat. Metab."},{"key":"1514_CR169","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s43587-022-00174-3","volume":"2","author":"GE Janssens","year":"2022","unstructured":"Janssens, G. E. et al. Healthy aging and muscle function are positively associated with NAD+ abundance in humans. Nat. Aging 2, 254\u2013263 (2022).","journal-title":"Nat. Aging"},{"key":"1514_CR170","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","volume":"14","author":"J Yoshino","year":"2011","unstructured":"Yoshino, J., Mills, K. F., Yoon, M. J. & Imai, S. Nicotinamide mononucleotide, a key NAD+ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 14, 528\u2013536 (2011).","journal-title":"Cell Metab."},{"key":"1514_CR171","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14139","volume":"7","author":"RM de Guia","year":"2019","unstructured":"de Guia, R. M. et al. Aerobic and resistance exercise training reverses age-dependent decline in NAD+ salvage capacity in human skeletal muscle. Physiol. Rep. 7, e14139 (2019).","journal-title":"Physiol. Rep."},{"key":"1514_CR172","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf2693","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. NAD+ repletion improves mitochondrial and stem cell function and enhances life span in mice. Science https:\/\/doi.org\/10.1126\/science.aaf2693 (2016).","journal-title":"Science"},{"key":"1514_CR173","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cmet.2016.05.006","volume":"23","author":"J Camacho-Pereira","year":"2016","unstructured":"Camacho-Pereira, J. et al. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 23, 1127\u20131139 (2016).","journal-title":"Cell Metab."},{"key":"1514_CR174","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cmet.2018.03.016","volume":"27","author":"MG Tarrag\u00f3","year":"2018","unstructured":"Tarrag\u00f3, M. G. et al. A potent and specific CD38 inhibitor ameliorates age-related metabolic dysfunction by reversing tissue NAD+ decline. Cell Metab. 27, 1081\u20131095.e10 (2018).","journal-title":"Cell Metab."},{"key":"1514_CR175","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cell.2018.02.008","volume":"173","author":"A Das","year":"2018","unstructured":"Das, A. et al. Impairment of an endothelial NAD+\u2013H2S signaling network is a reversible cause of vascular aging. Cell 173, 74\u201389.e20 (2018).","journal-title":"Cell"},{"key":"1514_CR176","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cmet.2017.11.002","volume":"27","author":"J Yoshino","year":"2018","unstructured":"Yoshino, J., Baur, J. A. & Imai, S.-I. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metab. 27, 513\u2013528 (2018).","journal-title":"Cell Metab."},{"key":"1514_CR177","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42255-025-01421-8","volume":"8","author":"S Christen","year":"2026","unstructured":"Christen, S. et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat. Metab. 8, 62\u201373 (2026).","journal-title":"Nat. Metab."},{"key":"1514_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108660","volume":"34","author":"M Romani","year":"2021","unstructured":"Romani, M. et al. NAD+ boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle. Cell Rep. 34, 108660 (2021).","journal-title":"Cell Rep."},{"key":"1514_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03421-7","volume":"9","author":"CR Martens","year":"2018","unstructured":"Martens, C. R. et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat. Commun. 9, 1286 (2018).","journal-title":"Nat. Commun."},{"key":"1514_CR180","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00394-019-01919-4","volume":"59","author":"CF Dolopikou","year":"2020","unstructured":"Dolopikou, C. F. et al. Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study. Eur. J. Nutr. 59, 505\u2013515 (2020).","journal-title":"Eur. J. Nutr."},{"key":"1514_CR181","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.158314","author":"JB Jensen","year":"2022","unstructured":"Jensen, J. B. et al. A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.158314 (2022).","journal-title":"JCI Insight"},{"key":"1514_CR182","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s11101-014-9375-z","volume":"14","author":"H Ashihara","year":"2015","unstructured":"Ashihara, H. et al. Trigonelline and related nicotinic acid metabolites: occurrence, biosynthesis, taxonomic considerations, and their roles in planta and in human health. Phytochem. Rev. 14, 765\u2013798 (2015).","journal-title":"Phytochem. Rev."},{"key":"1514_CR183","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/gutjnl-2016-313627","volume":"67","author":"W Barton","year":"2018","unstructured":"Barton, W. et al. The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut 67, 625\u2013633 (2018).","journal-title":"Gut"},{"key":"1514_CR184","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s42255-024-00997-x","volume":"6","author":"M Membrez","year":"2024","unstructured":"Membrez, M. et al. Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia. Nat. Metab. 6, 433\u2013447 (2024).","journal-title":"Nat. Metab."},{"key":"1514_CR185","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.cmet.2025.04.002","volume":"37","author":"S Chubanava","year":"2025","unstructured":"Chubanava, S. et al. NAD depletion in skeletal muscle does not compromise muscle function or accelerate aging. Cell Metab. 37, 1460\u20131481.e17 (2025).","journal-title":"Cell Metab."},{"key":"1514_CR186","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cmet.2016.07.005","volume":"24","author":"DW Frederick","year":"2016","unstructured":"Frederick, D. W. et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab. 24, 269\u2013282 (2016).","journal-title":"Cell Metab."},{"key":"1514_CR187","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/s42255-025-01387-7","volume":"7","author":"KT Vinten","year":"2025","unstructured":"Vinten, K. T. et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nat. Metab. 7, 1974\u20131990 (2025).","journal-title":"Nat. Metab."},{"key":"1514_CR188","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/1091581815619764","volume":"35","author":"AE Clewell","year":"2016","unstructured":"Clewell, A. E. et al. A comprehensive toxicological safety assessment of an extract of Olea europaea L. leaves (BonoliveTM). Int. J. Toxicol. 35, 208\u2013221 (2016).","journal-title":"Int. J. Toxicol."},{"key":"1514_CR189","doi-asserted-by":"publisher","first-page":"18508","DOI":"10.3390\/ijms151018508","volume":"15","author":"B Barbaro","year":"2014","unstructured":"Barbaro, B. et al. Effects of the olive-derived polyphenol oleuropein on human health. Int. J. Mol. Sci. 15, 18508\u201318524 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"1514_CR190","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cmet.2024.10.021","volume":"37","author":"G Gherardi","year":"2024","unstructured":"Gherardi, G. et al. Mitochondrial calcium uptake declines during aging and is directly activated by oleuropein to boost energy metabolism and skeletal muscle performance. Cell Metab. 37, 477\u2013495.e11 (2024).","journal-title":"Cell Metab."},{"key":"1514_CR191","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13005","volume":"4","author":"S Zampieri","year":"2016","unstructured":"Zampieri, S. et al. Physical exercise in aging human skeletal muscle increases mitochondrial calcium uniporter expression levels and affects mitochondria dynamics. Physiol. Rep. 4, e13005 (2016).","journal-title":"Physiol. Rep."},{"key":"1514_CR192","doi-asserted-by":"publisher","first-page":"35358","DOI":"10.18632\/oncotarget.6139","volume":"6","author":"L Pietrangelo","year":"2015","unstructured":"Pietrangelo, L. et al. Age-dependent uncoupling of mitochondria from Ca2+ release units in skeletal muscle. Oncotarget 6, 35358\u201335371 (2015).","journal-title":"Oncotarget"},{"key":"1514_CR193","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1152\/physrev.00041.2020","volume":"102","author":"JF Garbincius","year":"2022","unstructured":"Garbincius, J. F. & Elrod, J. W. Mitochondrial calcium exchange in physiology and disease. Physiol. Rev. 102, 893\u2013992 (2022).","journal-title":"Physiol. Rev."},{"key":"1514_CR194","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2340","volume":"348","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348, aaa2340 (2015).","journal-title":"Science"},{"key":"1514_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103244","volume":"65","author":"A Singh","year":"2021","unstructured":"Singh, A., Faccenda, D. & Campanella, M. Pharmacological advances in mitochondrial therapy. EBioMedicine 65, 103244 (2021).","journal-title":"EBioMedicine"},{"key":"1514_CR196","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X211070205","volume":"14","author":"M-N Horcajada","year":"2022","unstructured":"Horcajada, M.-N. et al. An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and post hoc analysis. Ther. Adv. Musculoskelet. Dis. 14, 1759720X211070205 (2022).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"1514_CR197","doi-asserted-by":"publisher","first-page":"15363","DOI":"10.1073\/pnas.2002250117","volume":"117","author":"JD Chavez","year":"2020","unstructured":"Chavez, J. D. et al. Mitochondrial protein interaction landscape of SS-31. Proc. Natl Acad. Sci. USA 117, 15363\u201315373 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR198","doi-asserted-by":"publisher","first-page":"e1212","DOI":"10.1212\/WNL.0000000000005255","volume":"90","author":"A Karaa","year":"2018","unstructured":"Karaa, A. et al. Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy. Neurology 90, e1212\u2013e1221 (2018).","journal-title":"Neurology"},{"key":"1514_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.111212","volume":"27","author":"H Kumagai","year":"2024","unstructured":"Kumagai, H. et al. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience 27, 111212 (2024).","journal-title":"iScience"},{"key":"1514_CR200","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20790-0","volume":"12","author":"JC Reynolds","year":"2021","unstructured":"Reynolds, J. C. et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nat. Commun. 12, 470 (2021).","journal-title":"Nat. Commun."},{"key":"1514_CR201","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.afos.2025.05.008","volume":"11","author":"H Kim","year":"2025","unstructured":"Kim, H., Kim, J., Lee, C. & Kim, S. Nutrition and exercise for sarcopenia treatment. Osteoporos. Sarcopenia 11, 54\u201364 (2025).","journal-title":"Osteoporos. Sarcopenia"},{"key":"1514_CR202","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/jcsm.13225","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen, Y. et al. Exercise for sarcopenia in older people: a systematic review and network meta-analysis. J. Cachexia Sarcopenia Muscle 14, 1199\u20131211 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR203","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ggi.70275","volume":"25","author":"M Kuzuya","year":"2025","unstructured":"Kuzuya, M. et al. Nutritional management guidelines for sarcopenia and frailty 2025. Geriatrics Gerontol. Int. 25, 5\u201353 (2025).","journal-title":"Geriatrics Gerontol. Int."},{"key":"1514_CR204","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ajcnut.2023.08.015","volume":"118","author":"S Robinson","year":"2023","unstructured":"Robinson, S., Granic, A., Cruz-Jentoft, A. J. & Sayer, A. A. The role of nutrition in the prevention of sarcopenia. Am. J. Clin. Nutr. 118, 852\u2013864 (2023).","journal-title":"Am. J. Clin. Nutr."},{"key":"1514_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18140-1","volume":"11","author":"DJ Ham","year":"2020","unstructured":"Ham, D. J. et al. The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia. Nat. Commun. 11, 4510 (2020).","journal-title":"Nat. Commun."},{"key":"1514_CR206","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00141-19","volume":"39","author":"GA Joseph","year":"2019","unstructured":"Joseph, G. A. et al. Partial inhibition of mTORC1 in aged rats counteracts the decline in muscle mass and reverses molecular signaling associated with sarcopenia. Mol. Cell Biol. 39, e00141-19 (2019).","journal-title":"Mol. Cell Biol."},{"key":"1514_CR207","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2015.02.015","volume":"65","author":"MM Markofski","year":"2015","unstructured":"Markofski, M. M. et al. Effect of age on basal muscle protein synthesis and mTORC1 signaling in a large cohort of young and older men and women. Exp. Gerontol. 65, 1\u20137 (2015).","journal-title":"Exp. Gerontol."},{"key":"1514_CR208","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004809","volume":"7","author":"H Tang","year":"2014","unstructured":"Tang, H. et al. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of foxO and E3 ubiquitin ligases. Sci. Signal. 7, ra18 (2014).","journal-title":"Sci. Signal."},{"key":"1514_CR209","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biocel.2016.06.012","volume":"78","author":"Z White","year":"2016","unstructured":"White, Z., White, R. B., McMahon, C., Grounds, M. D. & Shavlakadze, T. High mTORC1 signaling is maintained, while protein degradation pathways are perturbed in old murine skeletal muscles in the fasted state. Int. J. Biochem. Cell Biol. 78, 10\u201321 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1514_CR210","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.exger.2018.02.021","volume":"106","author":"J Bielas","year":"2018","unstructured":"Bielas, J. et al. Long term rapamycin treatment improves mitochondrial DNA quality in aging mice. Exp. Gerontol. 106, 125\u2013131 (2018).","journal-title":"Exp. Gerontol."},{"key":"1514_CR211","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jcsm.12505","volume":"11","author":"AS Ham","year":"2020","unstructured":"Ham, A. S. et al. mTORC1 signalling is not essential for the maintenance of muscle mass and function in adult sedentary mice. J. Cachexia Sarcopenia Muscle 11, 259\u2013273 (2020).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR212","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s43587-023-00416-y","volume":"3","author":"JB Mannick","year":"2023","unstructured":"Mannick, J. B. & Lamming, D. W. Targeting the biology of aging with mTOR inhibitors. Nat. Aging 3, 642\u2013660 (2023).","journal-title":"Nat. Aging"},{"key":"1514_CR213","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaq1564","volume":"10","author":"JB Mannick","year":"2018","unstructured":"Mannick, J. B. et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci. Transl. Med. 10, eaaq1564 (2018).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR214","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20123-1","volume":"12","author":"R Sartori","year":"2021","unstructured":"Sartori, R., Romanello, V. & Sandri, M. Mechanisms of muscle atrophy and hypertrophy: implications in health and disease. Nat. Commun. 12, 330 (2021).","journal-title":"Nat. Commun."},{"key":"1514_CR215","doi-asserted-by":"publisher","first-page":"1","DOI":"10.17987\/jcsm-cr.v2i1.37","volume":"2","author":"M Saitoh","year":"2017","unstructured":"Saitoh, M. et al. Myostatin inhibitors as pharmacological treatment for muscle wasting and muscular dystrophy. JCSM Clin. Rep. 2, 1\u201310 (2017).","journal-title":"JCSM Clin. Rep."},{"key":"1514_CR216","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-015-0060-8","volume":"5","author":"E Latres","year":"2015","unstructured":"Latres, E. et al. Myostatin blockade with a fully human monoclonal antibody induces muscle hypertrophy and reverses muscle atrophy in young and aged mice. Skelet. Muscle 5, 34 (2015).","journal-title":"Skelet. Muscle"},{"key":"1514_CR217","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1073\/pnas.1525795113","volume":"113","author":"J-PG Camporez","year":"2016","unstructured":"Camporez, J.-P. G. et al. Anti-myostatin antibody increases muscle mass and strength and improves insulin sensitivity in old mice. Proc. Natl Acad. Sci. USA 113, 2212\u20132217 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR218","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/MCB.01307-13","volume":"34","author":"E Lach-Trifilieff","year":"2014","unstructured":"Lach-Trifilieff, E. et al. An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy. Mol. Cell Biol. 34, 606\u2013618 (2014).","journal-title":"Mol. Cell Biol."},{"key":"1514_CR219","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","volume":"3","author":"C Becker","year":"2015","unstructured":"Becker, C. et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 3, 948\u2013957 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1514_CR220","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.20836","volume":"3","author":"D Rooks","year":"2020","unstructured":"Rooks, D. et al. Bimagrumab vs optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw. Open 3, e2020836 (2020).","journal-title":"JAMA Netw. Open"},{"key":"1514_CR221","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1111\/jgs.14927","volume":"65","author":"D Rooks","year":"2017","unstructured":"Rooks, D. et al. Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study. J. Am. Geriatr. Soc. 65, 1988\u20131995 (2017).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1514_CR222","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1007\/s12325-021-01757-z","volume":"38","author":"D Barrett","year":"2021","unstructured":"Barrett, D. et al. A randomized phase 1 safety, pharmacokinetic and pharmacodynamic study of the novel myostatin inhibitor apitegromab (SRK-015): a potential treatment for spinal muscular atrophy. Adv. Ther. 38, 3203\u20133222 (2021).","journal-title":"Adv. Ther."},{"key":"1514_CR223","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1210\/endo-119-5-2214","volume":"119","author":"EM Costa","year":"1986","unstructured":"Costa, E. M., Blau, H. M. & Feldman, D. 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 119, 2214\u20132220 (1986).","journal-title":"Endocrinology"},{"key":"1514_CR224","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/nature05883","volume":"447","author":"TE North","year":"2007","unstructured":"North, T. E. et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447, 1007\u20131011 (2007).","journal-title":"Nature"},{"key":"1514_CR225","doi-asserted-by":"publisher","first-page":"8716","DOI":"10.1016\/S0021-9258(18)34187-5","volume":"257","author":"HP Rodemann","year":"1982","unstructured":"Rodemann, H. P., Waxman, L. & Goldberg, A. L. The stimulation of protein degradation in muscle by Ca2+ is mediated by prostaglandin E2 and does not require the calcium-activated protease. J. Biol. Chem. 257, 8716\u20138723 (1982).","journal-title":"J. Biol. Chem."},{"key":"1514_CR226","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/S0021-9258(19)68084-1","volume":"257","author":"HP Rodemann","year":"1982","unstructured":"Rodemann, H. P. & Goldberg, A. L. Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J. Biol. Chem. 257, 1632\u20131638 (1982).","journal-title":"J. Biol. Chem."},{"key":"1514_CR227","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1194\/jlr.D013441","volume":"52","author":"SA Brose","year":"2011","unstructured":"Brose, S. A., Thuen, B. T. & Golovko, M. Y. LC\/MS\/MS method for analysis of E2 series prostaglandins and isoprostanes. J. Lipid Res. 52, 850\u2013859 (2011).","journal-title":"J. Lipid Res."},{"key":"1514_CR228","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/ajh.2012.67","volume":"25","author":"T Yang","year":"2012","unstructured":"Yang, T. & Du, Y. Distinct roles of central and peripheral prostaglandin E2 and EP subtypes in blood pressure regulation. Am. J. Hypertens. 25, 1042\u20131049 (2012).","journal-title":"Am. J. Hypertens."},{"key":"1514_CR229","unstructured":"Epirium Bio. Epirium Bio announces positive phase 1 clinical trial results evaluating MF-300 in healthy volunteers. https:\/\/epirium.com\/wp-content\/uploads\/2025\/09\/09-24-25-Epirium-Bio-Announces-Positive-Phase-1-Clinical-Trial-Results-Evaluating-MF-300-in-Healthy-Volunteers.pdf (2025)."},{"key":"1514_CR230","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igae098.3672","volume":"8","author":"M Webster","year":"2024","unstructured":"Webster, M., Martin, J., Fahr, B. & Khairallah, R. MF-300 (15-PGDH enzyme inhibitor) reverses age-related muscle weakness in mice by restoring muscle quality. Innov. Aging 8, 1145 (2024).","journal-title":"Innov. Aging"},{"key":"1514_CR231","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/j.nmd.2023.07.380","volume":"33","author":"M Webster","year":"2023","unstructured":"Webster, M. et al. P03 administration of MF-300, an orally bioavailable small molecule inhibitor of 15-PGDH, demonstrates improved muscle force in preclinical models of neuromuscular dysfunction and disease. Neuromuscul. Disord. 33, S162\u2013S163 (2023).","journal-title":"Neuromuscul. Disord."},{"key":"1514_CR232","doi-asserted-by":"publisher","DOI":"10.1093\/geroni\/igaf122.3994","volume":"9","author":"L MacConell","year":"2025","unstructured":"MacConell, L., Shah, A., Mould, D., Lavu, S. & Webster, M. Phase 1 evaluation of MF-300: an investigational first-in-class oral candidate for sarcopenia. Innov. Aging 9, igaf122.3994 (2025).","journal-title":"Innov. Aging"},{"key":"1514_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68336-0","volume":"10","author":"JNP Smith","year":"2020","unstructured":"Smith, J. N. P. et al. Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis. Sci. Rep. 10, 11657 (2020).","journal-title":"Sci. Rep."},{"key":"1514_CR234","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/0886022X.2020.1870139","volume":"43","author":"BW Kim","year":"2021","unstructured":"Kim, B. W. et al. 15-Hydroxyprostaglandin dehydrogenase inhibitor prevents contrast-induced acute kidney injury. Ren. Fail. 43, 168\u2013179 (2021).","journal-title":"Ren. Fail."},{"key":"1514_CR235","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268787","volume":"17","author":"WJ Ho","year":"2022","unstructured":"Ho, W. J. et al. 15-PGDH regulates hematopoietic and gastrointestinal fitness during aging. PLoS ONE 17, e0268787 (2022).","journal-title":"PLoS ONE"},{"key":"1514_CR236","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2417224122","volume":"122","author":"Y Koh","year":"2025","unstructured":"Koh, Y. et al. Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer\u2019s disease and traumatic brain injury. Proc. Natl Acad. Sci. USA 122, e2417224122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR237","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.adx6649","volume":"391","author":"M Singla","year":"2025","unstructured":"Singla, M. et al. Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science 391, 1053\u20131062 (2025).","journal-title":"Science"},{"key":"1514_CR238","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/gerona\/61.2.182","volume":"61","author":"M Maggio","year":"2006","unstructured":"Maggio, M., Ble, A., Ceda, G. P. & Metter, E. J. Decline in insulin-like growth factor-I levels across adult life span in two large population studies. J. Gerontol. A 61, 182\u2013183 (2006).","journal-title":"J. Gerontol. A"},{"key":"1514_CR239","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.beem.2013.05.003","volume":"27","author":"FR Sattler","year":"2013","unstructured":"Sattler, F. R. Growth hormone in the aging male. Best Pract. Res. Clin. Endocrinol. Metab. 27, 541\u2013555 (2013).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"1514_CR240","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155597","volume":"149","author":"Y Rolland","year":"2023","unstructured":"Rolland, Y., Dray, C., Vellas, B. & Barreto, P. D. S. Current and investigational medications for the treatment of sarcopenia. Metab. Clin. Exp. 149, 155597 (2023).","journal-title":"Metab. Clin. Exp."},{"key":"1514_CR241","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1365-2265.2009.03592.x","volume":"71","author":"KZ Rubeck","year":"2009","unstructured":"Rubeck, K. Z., Bertelsen, S., Vestergaard, P. & J\u00f8rgensen, J. O. L. Impact of GH substitution on exercise capacity and muscle strength in GH-deficient adults: a meta-analysis of blinded, placebo-controlled trials. Clin. Endocrinol. 71, 860\u2013866 (2009).","journal-title":"Clin. Endocrinol."},{"key":"1514_CR242","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1365-2265.2009.03716.x","volume":"72","author":"WM Widdowson","year":"2010","unstructured":"Widdowson, W. M. & Gibney, J. The effect of growth hormone (GH) replacement on muscle strength in patients with GH-deficiency: a meta-analysis. Clin. Endocrinol. 72, 787\u2013792 (2010).","journal-title":"Clin. Endocrinol."},{"key":"1514_CR243","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1532-5415.1998.tb02714.x","volume":"46","author":"DP Kiel","year":"1998","unstructured":"Kiel, D. P. et al. Lack of an association between insulin-like growth factor-I and body composition, muscle strength, physical performance or self-reported mobility among older persons with functional limitations. J. Am. Geriatr. Soc. 46, 822\u2013828 (1998).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1514_CR244","doi-asserted-by":"publisher","first-page":"586","DOI":"10.2174\/1381612827666211115155541","volume":"28","author":"C Correa","year":"2022","unstructured":"Correa, C., Bieger, P., Perry, I. S. & Souza, G. C. Testosterone supplementation on sarcopenia components in chronic patients: a systematic review and meta-analysis. Curr. Pharm. Des. 28, 586\u2013594 (2022).","journal-title":"Curr. Pharm. Des."},{"key":"1514_CR245","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2020.111106","volume":"142","author":"SM Parahiba","year":"2020","unstructured":"Parahiba, S. M. et al. Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: a systematic review and meta-analysis. Exp. Gerontol. 142, 111106 (2020).","journal-title":"Exp. Gerontol."},{"key":"1514_CR246","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMp1506632","volume":"373","author":"CP Nguyen","year":"2015","unstructured":"Nguyen, C. P. et al. Testosterone and \u201cage-related hypogonadism\u201d \u2014 FDA concerns. N. Engl. J. Med. 373, 689\u2013691 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1514_CR247","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102620","volume":"56","author":"Y Hu","year":"2021","unstructured":"Hu, Y., Wan, P., An, X. & Jiang, G. Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: a meta-analysis of randomized controlled trials. Complement. Ther. Med. 56, 102620 (2021).","journal-title":"Complement. Ther. Med."},{"key":"1514_CR248","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1056\/NEJMoa054629","volume":"355","author":"KS Nair","year":"2006","unstructured":"Nair, K. S. et al. DHEA in elderly women and DHEA or testosterone in elderly men. N. Engl. J. Med. 355, 1647\u20131659 (2006).","journal-title":"N. Engl. J. Med."},{"key":"1514_CR249","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1532-5415.2010.03019.x","volume":"58","author":"AM Kenny","year":"2010","unstructured":"Kenny, A. M. et al. Dehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older women. J. Am. Geriatr. Soc. 58, 1707\u20131714 (2010).","journal-title":"J. Am. Geriatr. Soc."},{"key":"1514_CR250","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.10154","volume":"2","author":"AA Javed","year":"2019","unstructured":"Javed, A. A., Mayhew, A. J., Shea, A. K. & Raina, P. Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis. JAMA Netw. Open 2, e1910154 (2019).","journal-title":"JAMA Netw. Open"},{"key":"1514_CR251","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/gerona\/glp082","volume":"64","author":"SM Greising","year":"2009","unstructured":"Greising, S. M., Baltgalvis, K. A., Lowe, D. A. & Warren, G. L. Hormone therapy and skeletal muscle strength: a meta-analysis. J. Gerontol. A 64, 1071\u20131081 (2009).","journal-title":"J. Gerontol. A"},{"key":"1514_CR252","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1021\/acsmedchemlett.5b00377","volume":"7","author":"AL Handlon","year":"2016","unstructured":"Handlon, A. L. et al. Optimizing ligand efficiency of selective androgen receptor modulators (SARMs). ACS Med. Chem. Lett. 7, 83\u201388 (2016).","journal-title":"ACS Med. Chem. Lett."},{"key":"1514_CR253","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","volume":"2","author":"JT Dalton","year":"2011","unstructured":"Dalton, J. T. et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J. Cachexia Sarcopenia Muscle 2, 153\u2013161 (2011).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR254","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","volume":"17","author":"DA Papanicolaou","year":"2013","unstructured":"Papanicolaou, D. A. et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. J. Nutr. Health Aging 17, 533\u2013543 (2013).","journal-title":"J. Nutr. Health Aging"},{"key":"1514_CR255","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/13543784.2020.1777275","volume":"29","author":"GWPD Fonseca","year":"2020","unstructured":"Fonseca, G. W. P. D., Dworatzek, E., Ebner, N. & Von Haehling, S. Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials. Expert Opin. Investig. Drugs 29, 881\u2013891 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"1514_CR256","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-pharmtox-010818-021041","volume":"59","author":"R Furrer","year":"2019","unstructured":"Furrer, R. & Handschin, C. Muscle wasting diseases: novel targets and treatments. Annu. Rev. Pharmacol. Toxicol. 59, 315\u2013339 (2019).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"1514_CR257","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/cncr.22944","volume":"110","author":"A Jatoi","year":"2007","unstructured":"Jatoi, A. et al. A placebo-controlled double blind trial of etanercept for the cancer anorexia\/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer 110, 1396\u20131403 (2007).","journal-title":"Cancer"},{"key":"1514_CR258","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","volume":"162","author":"AJ Johnston","year":"2015","unstructured":"Johnston, A. J. et al. Targeting of Fn14 prevents cancer-induced cachexia and prolongs survival. Cell 162, 1365\u20131378 (2015).","journal-title":"Cell"},{"key":"1514_CR259","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202402885","volume":"7","author":"JB Shrager","year":"2024","unstructured":"Shrager, J. B. et al. JAK inhibition with tofacitinib rapidly increases contractile force in human skeletal muscle. Life Sci. Alliance 7, e202402885 (2024).","journal-title":"Life Sci. Alliance"},{"key":"1514_CR260","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","volume":"22","author":"Y Cao","year":"2023","unstructured":"Cao, Y., Langer, R. & Ferrara, N. Targeting angiogenesis in oncology, ophthalmology and beyond. Nat. Rev. Drug Discov. 22, 476\u2013495 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1514_CR261","doi-asserted-by":"publisher","first-page":"287","DOI":"10.14336\/AD.2016.0920","volume":"8","author":"G Zhao","year":"2017","unstructured":"Zhao, G. et al. The soluble VEGF receptor sFlt-1 contributes to impaired neovascularization in aged mice. Aging Dis. 8, 287\u2013300 (2017).","journal-title":"Aging Dis."},{"key":"1514_CR262","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc8479","volume":"373","author":"M Grunewald","year":"2021","unstructured":"Grunewald, M. et al. Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span. Science 373, eabc8479 (2021).","journal-title":"Science"},{"key":"1514_CR263","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jcsm.13326","volume":"15","author":"M Serova","year":"2023","unstructured":"Serova, M. et al. BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice. J. Cachexia Sarcopenia Muscle 15, 55\u201366 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR264","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002227","volume":"3","author":"TN Burks","year":"2011","unstructured":"Burks, T. N. et al. Losartan restores skeletal muscle remodeling and protects against disuse atrophy in sarcopenia. Sci. Transl. Med. 3, 82ra37 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR265","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1249\/MSS.0000000000001438","volume":"50","author":"MF Heisterberg","year":"2018","unstructured":"Heisterberg, M. F. et al. Effect of losartan on the acute response of human elderly skeletal muscle to exercise. Med. Sci. Sports Exerc. 50, 225\u2013235 (2018).","journal-title":"Med. Sci. Sports Exerc."},{"key":"1514_CR266","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0140-6736(02)08024-8","volume":"359","author":"G Onder","year":"2002","unstructured":"Onder, G. et al. Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study. Lancet 359, 926\u2013930 (2002).","journal-title":"Lancet"},{"key":"1514_CR267","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1038\/s41591-018-0131-6","volume":"24","author":"C Vinel","year":"2018","unstructured":"Vinel, C. et al. The exerkine apelin reverses age-associated sarcopenia. Nat. Med. 24, 1360\u20131371 (2018).","journal-title":"Nat. Med."},{"key":"1514_CR268","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn8529","volume":"16","author":"E Le Moal","year":"2024","unstructured":"Le Moal, E. et al. Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice. Sci. Transl. Med. 16, eabn8529 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1514_CR269","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176794","volume":"978","author":"M Telesca","year":"2024","unstructured":"Telesca, M. et al. Effects of sacubitril-valsartan on aging-related cardiac dysfunction. Eur. J. Pharmacol. 978, 176794 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"1514_CR270","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1126\/science.aab3388","volume":"350","author":"MA Goodell","year":"2015","unstructured":"Goodell, M. A. & Rando, T. A. Stem cells and healthy aging. Science 350, 1199\u20131204 (2015).","journal-title":"Science"},{"key":"1514_CR271","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/bs.ctdb.2017.08.003","volume":"126","author":"O Mashinchian","year":"2018","unstructured":"Mashinchian, O., Pisconti, A., Le Moal, E. & Bentzinger, C. F. The muscle stem cell niche in health and disease. Curr. Top. Dev. Biol. 126, 23\u201365 (2018).","journal-title":"Curr. Top. Dev. Biol."},{"key":"1514_CR272","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nature03260","volume":"433","author":"IM Conboy","year":"2005","unstructured":"Conboy, I. M. et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433, 760\u2013764 (2005).","journal-title":"Nature"},{"key":"1514_CR273","unstructured":"Satellos. Satellos announces new data further demonstrating safety, tolerability, and functional impact of SAT-3247 in first-in-human trial of adults with Duchenne muscular dystrophy. https:\/\/ir.satellos.com\/news\/news-details\/2025\/Satellos-Announces-New-Data-Further-Demonstrating-Safety-Tolerability-and-Functional-Impact-of-SAT-3247-in-First-in-Human-Trial-of-Adults-with-Duchenne-Muscular-Dystrophy\/default.aspx (2025)."},{"key":"1514_CR274","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nm.3465","volume":"20","author":"JD Bernet","year":"2014","unstructured":"Bernet, J. D. et al. p38 MAPK signaling underlies a cell-autonomous loss of stem cell self-renewal in skeletal muscle of aged mice. Nat. Med. 20, 265\u2013271 (2014).","journal-title":"Nat. Med."},{"key":"1514_CR275","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/nm.3655","volume":"20","author":"FD Price","year":"2014","unstructured":"Price, F. D. et al. Inhibition of JAK-STAT signaling stimulates adult satellite cell function. Nat. Med. 20, 1174\u20131181 (2014).","journal-title":"Nat. Med."},{"key":"1514_CR276","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03876-8","volume":"9","author":"SC Sampath","year":"2018","unstructured":"Sampath, S. C. et al. Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin M. Nat. Commun. 9, 1531 (2018).","journal-title":"Nat. Commun."},{"key":"1514_CR277","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2606533123","volume":"123","author":"M Nalbandian","year":"2026","unstructured":"Nalbandian, M. et al. 15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss. Proc. Natl Acad. Sci. USA 123, e2606533123 (2026).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1514_CR278","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163648","volume":"134","author":"S Ancel","year":"2024","unstructured":"Ancel, S. et al. Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging. J. Clin. Invest. 134, e163648 (2024).","journal-title":"J. Clin. Invest."},{"key":"1514_CR279","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013606","volume":"7","author":"G Shafiee","year":"2017","unstructured":"Shafiee, G. et al. Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open 7, e013606 (2017).","journal-title":"BMJ Open"},{"key":"1514_CR280","doi-asserted-by":"publisher","unstructured":"H\u00f8jfeldt, G. et al. Nicotinamide and pyridoxine supplementation stimulates muscle stem cells in a randomized clinical trial on muscle repair. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.03.24.25323226 (2025).","DOI":"10.1101\/2025.03.24.25323226"},{"key":"1514_CR281","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","volume":"393","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. & Sayer, A. A. Sarcopenia. Lancet 393, 2636\u20132646 (2019).","journal-title":"Lancet"},{"key":"1514_CR282","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2019.110801","volume":"131","author":"J Pacifico","year":"2020","unstructured":"Pacifico, J. et al. Prevalence of sarcopenia as a comorbid disease: a systematic review and meta-analysis. Exp. Gerontol. 131, 110801 (2020).","journal-title":"Exp. Gerontol."},{"key":"1514_CR283","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.jamda.2014.10.001","volume":"15","author":"JE Morley","year":"2014","unstructured":"Morley, J. E., Malmstrom, T. K., Rodriguez-Ma\u00f1as, L. & Sinclair, A. J. Frailty, sarcopenia and diabetes. J. Am. Med. Dir. Assoc. 15, 853\u2013859 (2014).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"1514_CR284","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcsm.12043","volume":"6","author":"TS Bowen","year":"2015","unstructured":"Bowen, T. S., Schuler, G. & Adams, V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle 6, 197\u2013207 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1514_CR285","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-023-00921-9","volume":"19","author":"JL Bennett","year":"2023","unstructured":"Bennett, J. L., Pratt, A. G., Dodds, R., Sayer, A. A. & Isaacs, J. D. Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat. Rev. Rheumatol. 19, 239\u2013251 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1514_CR286","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/ndt\/gfv133","volume":"30","author":"RA Pereira","year":"2015","unstructured":"Pereira, R. A. et al. Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol. Dial. Transplant. 30, 1718\u20131725 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"1514_CR287","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 39, 412\u2013423 (2010).","journal-title":"Age Ageing"},{"key":"1514_CR288","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding, R. A. et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J. Am. Med. Dir. Assoc. 12, 249\u2013256 (2011).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"1514_CR289","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","volume":"15","author":"L-K Chen","year":"2014","unstructured":"Chen, L.-K. et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J. Am. Med. Dir. Assoc. 15, 95\u2013101 (2014).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"1514_CR290","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen, L.-K. et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J. Am. Med. Dir. Assoc. 21, 300\u2013307.e2 (2020).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"1514_CR291","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/gerona\/glu010","volume":"69","author":"SA Studenski","year":"2014","unstructured":"Studenski, S. A. et al. The FNIH Sarcopenia Project: rationale, study description, conference recommendations, and final estimates. J. Gerontol. A 69, 547\u2013558 (2014).","journal-title":"J. Gerontol. A"},{"key":"1514_CR292","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1007\/s00330-019-06573-2","volume":"30","author":"D Albano","year":"2020","unstructured":"Albano, D., Messina, C., Vitale, J. & Sconfienza, L. M. Imaging of sarcopenia: old evidence and new insights. Eur. Radiol. 30, 2199\u20132208 (2020).","journal-title":"Eur. Radiol."},{"key":"1514_CR293","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2026.113109","volume":"217","author":"K Pus","year":"2026","unstructured":"Pus, K., Sarto, F., Narici, M. & \u0160imuni\u010d, B. The application of ultrasound sarcopenia index in sarcopenic population. Exp. Gerontol. 217, 113109 (2026).","journal-title":"Exp. Gerontol."},{"key":"1514_CR294","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cmet.2019.06.008","volume":"30","author":"G Colleluori","year":"2019","unstructured":"Colleluori, G. et al. Aerobic plus resistance exercise in obese older adults improves muscle protein synthesis and preserves myocellular quality despite weight loss. Cell Metab. 30, 261\u2013273.e6 (2019).","journal-title":"Cell Metab."},{"key":"1514_CR295","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","volume":"187","author":"CM Kusminski","year":"2024","unstructured":"Kusminski, C. M. et al. Transforming obesity: the advancement of multi-receptor drugs. Cell 187, 3829\u20133853 (2024).","journal-title":"Cell"},{"key":"1514_CR296","doi-asserted-by":"publisher","DOI":"10.2337\/db24-2057-LB","volume":"73","author":"K Klepac-Bartl","year":"2024","unstructured":"Klepac-Bartl, K. et al. Amino acids plasma levels do not correlate with lean mass loss in weight-matched DIO mice treated with survodutide or semaglutide. Diabetes 73, 2057-LB (2024).","journal-title":"Diabetes"},{"key":"1514_CR297","doi-asserted-by":"publisher","DOI":"10.1113\/JP289449","author":"S Jeromson","year":"2025","unstructured":"Jeromson, S. et al. Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet-induced obesity. J. Physiol. https:\/\/doi.org\/10.1113\/JP289449 (2025).","journal-title":"J. Physiol."},{"key":"1514_CR298","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3803\/EnM.2019.34.3.247","volume":"34","author":"JA Sargeant","year":"2019","unstructured":"Sargeant, J. A. et al. A review of the effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors on lean body mass in humans. Endocrinol. Metab. 34, 247\u2013262 (2019).","journal-title":"Endocrinol. Metab."},{"key":"1514_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2025.101708","volume":"52","author":"AJ Scheen","year":"2025","unstructured":"Scheen, A. J. GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations. Diabetes Metab. 52, 101708 (2025).","journal-title":"Diabetes Metab."},{"key":"1514_CR300","doi-asserted-by":"publisher","DOI":"10.2337\/db24-118-OR","volume":"73","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. The apelin receptor agonist azelaprag increases weight loss in diet-induced obese mice on incretin agonists and restores body composition and muscle function to that of lean controls. Diabetes 73, 118-OR (2024).","journal-title":"Diabetes"},{"key":"1514_CR301","unstructured":"BioAge Labs. BioAge Labs announces discontinuation of STRIDES phase 2 clinical trial evaluating azelaprag in combination with tirzepatide for the treatment of obesity. https:\/\/ir.bioagelabs.com\/news-releases\/news-release-details\/bioage-labs-announces-discontinuation-strides-phase-2-clinical\/ (2024)."},{"key":"1514_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101880","volume":"80","author":"E Nunn","year":"2024","unstructured":"Nunn, E. et al. Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism. Mol. Metab. 80, 101880 (2024).","journal-title":"Mol. Metab."},{"key":"1514_CR303","unstructured":"American Diabetes Association. New GLP-1 therapies enhance quality of weight loss by improving muscle preservation. https:\/\/diabetes.org\/newsroom\/press-releases\/new-glp-1-therapies-enhance-quality-weight-loss-improving-muscle-0 (2025)."},{"key":"1514_CR304","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59485-9","volume":"16","author":"JW Mastaitis","year":"2025","unstructured":"Mastaitis, J. W. et al. GDF8 and activin a blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates. Nat. Commun. 16, 4377 (2025).","journal-title":"Nat. Commun."},{"key":"1514_CR305","unstructured":"Regeneron Pharmaceuticals Inc. Interim results from ongoing phase 2 COURAGE trial confirm potential to improve the quality of semaglutide (GLP-1 receptor agonist)-induced weight loss by preserving lean mass. https:\/\/newsroom.regeneron.com\/news-releases\/news-release-details\/interim-results-ongoing-phase-2-courage-trial-confirm-potential\/ (2025)."},{"key":"1514_CR306","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.cell.2023.08.003","volume":"186","author":"M Moqri","year":"2023","unstructured":"Moqri, M. et al. Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186, 3758\u20133775 (2023).","journal-title":"Cell"},{"key":"1514_CR307","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","volume":"19","author":"S Horvath","year":"2018","unstructured":"Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet. 19, 371\u2013384 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1514_CR308","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).","journal-title":"Genome Biol."},{"key":"1514_CR309","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.cmet.2017.03.016","volume":"25","author":"DA Petkovich","year":"2017","unstructured":"Petkovich, D. A. et al. Using DNA methylation profiling to evaluate biological age and longevity interventions. Cell Metab. 25, 954\u2013960.e6 (2017).","journal-title":"Cell Metab."},{"key":"1514_CR310","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s43587-023-00451-9","volume":"3","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. Multi-omic rejuvenation and life span extension on exposure to youthful circulation. Nat. Aging 3, 948\u2013964 (2023).","journal-title":"Nat. Aging"},{"key":"1514_CR311","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s43587-025-00883-5","volume":"5","author":"M Fuentealba","year":"2025","unstructured":"Fuentealba, M. et al. A blood-based epigenetic clock for intrinsic capacity predicts mortality and is associated with clinical, immunological and lifestyle factors. Nat. Aging 5, 1207\u20131216 (2025).","journal-title":"Nat. Aging"},{"key":"1514_CR312","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s43587-024-00793-y","volume":"5","author":"HA Bischoff-Ferrari","year":"2025","unstructured":"Bischoff-Ferrari, H. A. et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nat. Aging 5, 376\u2013385 (2025).","journal-title":"Nat. Aging"}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01514-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:04:54Z","timestamp":1788793494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41573-026-01514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":312,"alternative-id":["1514"],"URL":"https:\/\/doi.org\/10.1038\/s41573-026-01514-3","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"9 July 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.M.B. is a cofounder of Myoforte\/Epirium Bio and has equity and stock options from Epirium Bio. H.M.B. and Y.X.W. are named inventors on patents regarding 15-PGDH inhibition. S.A. and Y.X.W. are currently employees of Nestl\u00e9 Institute of Health Sciences and Regeneron Pharmaceuticals, respectively. The contributions of S.A. and Y.X.W. to this work were completed before they joined companies, which had no role in the synthesis, manuscript preparation or decision to submit.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}